| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Generation Bio Co. | Director | Common Stock | 535K | $1.02M | $1.91 | Dec 4, 2023 | Direct |
| Viking Therapeutics, Inc. | Director | Common Stock, par value $0.00001 per share | 30K | $692K | $23.05 | May 16, 2023 | Direct |
| Blueprint Medicines Corp | Director | Common Stock | 5.81K | $523K | $90.00 | Jun 2, 2021 | Direct |
| Generation Bio Co. | Director | Stock Option (right to buy) | 60K | $275K | $4.59 | Jun 6, 2024 | Direct |
| Blueprint Medicines Corp | Director | Stock Option (Right to Buy) | 4.5K | $67.5K | $15.01 | Jun 2, 2021 | Direct |
| Nabriva Therapeutics plc | Director | Ordinary Shares | 15.3K | $22.9K | $1.50 | Aug 1, 2022 | Direct |
| Viking Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 32K | Jan 2, 2024 | Direct | ||
| Orchard Therapeutics plc | Director | Ordinary Shares | 0 | $0.46 | Jan 24, 2024 | Direct | |
| Orchard Therapeutics plc | Director | Stock Option (Right to Buy) | 0 | Jan 24, 2024 | Direct |